AXIN-AMPK signaling: Implications for healthy aging

Avijit Mallick; Bhagwati P. Gupta

doi:10.12688/f1000research.74220.1

Home Browse AXIN-AMPK signaling: Implications for healthy aging

ALL Metrics

-

Views

-

Downloads

Get PDF

Get XML

Export

▬

✚

Opinion Article

AXIN-AMPK signaling: Implications for healthy aging

[version 1; peer review: 1 approved, 2 approved with reservations]

Avijit Mallick¹, Bhagwati P. Gupta ¹

PUBLISHED 08 Dec 2021

Author details Author details

¹ Department of Biology, McMaster University, Hamilton, Ontario, L8S4K1, Canada

Avijit Mallick
Roles: Conceptualization, Data Curation, Formal Analysis, Validation, Writing – Original Draft Preparation, Writing – Review & Editing

Bhagwati P. Gupta
Roles: Conceptualization, Funding Acquisition, Project Administration, Resources, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing

OPEN PEER REVIEW

REVIEWER STATUS

Abstract

The energy sensor AMP kinase (AMPK) and the master scaffolding protein, AXIN, are two major regulators of biological processes in metazoans. AXIN-dependent regulation of AMPK activation plays a crucial role in maintaining metabolic homeostasis during glucose-deprived and energy-stressed conditions. The two proteins are also required for muscle function. While studies have refined our knowledge of various cellular events that promote the formation of AXIN-AMPK complexes and the involvement of effector proteins, more work is needed to understand precisely how the pathway is regulated in response to various forms of stress. In this review, we discuss recent data on AXIN and AMPK interaction and its role in physiological changes leading to improved muscle health and an extension of lifespan. We argue that AXIN-AMPK signaling plays an essential role in maintaining muscle function and manipulating the pathway in a tissue-specific manner could delay muscle aging. Therefore, research on understanding the factors that regulate AXIN-AMPK signaling holds the potential for developing novel therapeutics to slow down or revert the age-associated decline in muscle function, thereby extending the healthspan of animals.

Keywords

Axin, AMPK, muscle, aging, C. elegans, LKB1, AAK-2, PRY-1

Corresponding author: Bhagwati P. Gupta

Competing interests: No competing interests were disclosed.

Grant information: This work was supported by Natural Sciences and Engineering Research Council (NSERC) Discovery grant to BPG and NSERC CGS-D graduate scholarship to AM.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright: © 2021 Mallick A and Gupta BP. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite: Mallick A and Gupta BP. AXIN-AMPK signaling: Implications for healthy aging [version 1; peer review: 1 approved, 2 approved with reservations]. F1000Research 2021, 10:1259 (https://doi.org/10.12688/f1000research.74220.1) First published: 08 Dec 2021, 10:1259 (https://doi.org/10.12688/f1000research.74220.1) Latest published: 08 Dec 2021, 10:1259 (https://doi.org/10.12688/f1000research.74220.1)

Introduction

With aging, there is a decline in skeletal muscle mass and function. Aging muscle undergoes a shift in the balance between myogenic potential and fibrogenic activity that leads to reduced capacity of the muscle to repair and regenerate.¹ Studies have shown that age-associated decline in muscle function is multifactorial and affected by genetic and environmental factors. While many genes have been identified that contribute to muscle development and function, their mechanisms of action are not well understood.

This review discusses a novel signaling network involving AXIN and AMP-activated protein kinase (AMPK) in maintaining muscle health that offers a new perspective on promoting healthy aging. Both these proteins are conserved in metazoans. AXIN is an established scaffolding protein that acts to integrate inputs from multiple signaling molecules, leading to the regulation of downstream effectors.² AMPK plays a crucial role in sensing intracellular energy levels and keeping a balance between cellular metabolism and growth.³

AXIN-AMPK signaling

Recent findings from our lab and other published studies involving AXIN and its interacting partner AMPK provide a potential clue into the mechanism of muscle health maintenance. Work in the nematode C. elegans has revealed that the AXIN family member PRY-1 is necessary for animals’ normal motility and health, and its activated form promotes longevity by maintaining muscle mitochondrial homeostasis.⁴ A similar function was previously ascribed to the AMPK catalytic subunit homolog AAK-2.⁵^,⁶ The genetic and biochemical experiments revealed that PRY-1 and AAK-2 work together, likely through protein-protein interaction, and PRY-1 is required for AAK-2-mediated beneficial effect on muscle health and lifespan (Figure 1). The interaction between PRY-1 and AAK-2 is not a unique phenomenon, as other AXIN family members also interact with AMPK in different biological contexts. For example, another C. elegans AXIN homolog AXL-1 forms a complex with AAK-2 following metformin treatment. Here, AXL-1 is necessary for metformin-mediated lysosomal localization and activation of AAK-2 in a VHA-3-LMTR-3-PAR-4 (v-ATPase-Ragulator-LKB1) complex dependent manner⁷ (Figure 2).

Figure 1. PRY-1/AXIN function in the muscle is necessary to maintain muscle health, mitochondrial biogenesis and longevity.

Genetic and biochemical studies have shown that PRY-1/AXIN interacts with PAR-4/LKB1 and AAK-2/AMPK in muscles to promote AAK-2/AMPK phosphorylation. AAK-2 in turn activates DAF-16/FOXO cell non-autonomously in the intestine and promotes DAF-16/FOXO nuclear localization. Green colored P indicates activating phosphorylation.

Figure 2. AXL-1/AXIN is required for metformin-mediated AAK-2/AMPK phosphorylation and longer lifespan in C. elegans.

Metformin treatment induces formation of AXL-1/AXIN-based lysosomal VHA-3-LMTR-3-AXL-1/PAR-4-AAK-2 (v-ATPase-Ragulator-AXIN/LKB1-AMPK) complex that is required for AAK-2/AMPK activation. The effect of metformin is partially attained via inhibition of mTORC1, but other targets of the pathway remain unknown. Green colored P shows activating phosphorylation.

The Axin-containing complexes are also reported in mammalian systems. Following metformin treatment and glucose deprivation,⁸^–¹⁰ the AXIN-based lysosomal pathway, consisting of v-ATPase-Ragulator complex (v-ATPase-Ragulator-AXIN/LKB1-AMPK), promotes AMPK phosphorylation by LKB1, leading to AMPK activation. In a separate study involving myotubes and mice gastrocnemius muscle tissue, exercise stimulated both AMPK and Rac1 while increasing the cellular levels of AXIN1. Accordingly, reducing the AXIN1 function blocked GTP loading of Rac1, AMPK activation, and glucose uptake in the exercising muscles.¹¹ Additionally, it was shown that muscle-specific knockout (KO) of the AXIN1-binding Ragulator subunit LAMTOR1 completely abolished treadmill exercise-stimulated AMPK activation in gastrocnemius muscle.¹⁰ Together, these data demonstrate the crucial role of AXIN tethering in activating AMPK, which promotes muscle metabolism and benefits linked to exercise.

Investigations of cellular mechanisms underlying AXIN and AMPK interaction have revealed a regulatory relationship that depends on AMP levels¹² (Figure 3). While low glucose triggered AMP-dependent activation of AMPK through the AXIN-based lysosomal pathway, a modest increase in AMP resulted in AXIN-dependent activation of both lysosomal and cytosolic AMPK. Finally, extreme nutrient starvation or high AMP concentrations caused phosphorylation of AMPK independently of AXIN function.¹²

Figure 3. AXIN forms a lysosomal complex, v-ATPase-Ragulator-AXIN/LKB1-AMPK, that is crucial for AMPK activation and the maintenance of energy homeostasis during stress-inducing conditions.

The complex is formed following glucose deprivation, low to moderate increases in AMP levels, and metformin treatment. Once activated, AXIN-AMPK signaling promotes catabolism and inhibits anabolism by phosphorylating downstream targets that include ACC1, SREBP1c, Raptor and TSC2. Green and purple colored P indicate activating and inhibitory phosphorylation, respectively.

Intriguingly, it was shown recently that skeletal muscle-specific AXIN1 knockout (AXIN1 imKO) mice are phenotypically normal and exhibited no impairment of AMPK regulation or glucose uptake.¹³ Such a phenotype may be explained by redundancies between AXIN1 and its homolog AXIN2. Both proteins are expressed in skeletal muscles, and AXIN2 can functionally replace AXIN1 in regulating AMPK.¹²^,¹⁴ Moreover, AXIN2, a negative regulator of WNT signaling, appears to be essential for myogenesis, as increased WNT signaling in aged skeletal muscle promoted fibrogenesis, thereby accelerating aging.¹⁵^–¹⁷

Consistent with the role of AXIN in AMPK activation and myogenesis, AMPK is shown to be crucial for regulating skeletal muscle development, growth, and degradation.¹⁸ In skeletal muscle, AMPK signaling has been linked to both acute and chronic exercise adaptations, in addition to a broad range of skeletal muscle disease states and ageing.¹⁹^,²⁰ Together these data support the growing evidence that both AXIN and AMPK and their signaling cascade are crucial to maintaining healthy muscles and slowing organismal deterioration with aging.

Downstream effectors of AXIN-AMPK signaling

Studies in mammalian models revealed that both metformin and glucose deprivation inhibit the mechanistic target of rapamycin complex 1 (mTORC1) activity, a master regulator of anabolic pathways.⁸^,¹⁰ Both these treatments cause the mTORC1 components, RAPTOR and mTOR, to dissociate from the v-ATPase-Ragulator and facilitate the formation of the v-ATPase-Ragulator-AXIN/LKB1-AMPK complex. Similarly, research in C. elegans has demonstrated that the VHA-3-LMTR-3-AXL-1/PAR-4-AAK-2 complex negatively regulates phosphorylation of the mTORC1 target S6 kinase B1 (S6K) homolog RSKS-1.⁷ As the beneficial effects of AXIN-AMPK signaling in the C. elegans study were not directly attributed to mTORC1 inhibition, the authors suggested that the signaling cascade may utilize additional factors⁷ (Figure 2).

The downstream effectors of AXIN-AMPK have been reported in several other studies. Specifically, in a low glucose condition, the pathway phosphorylates proteins such as acetyl-CoA carboxylase (ACC1) and endoplasmic reticulum-localized sterol regulatory element-binding protein-1c (SREBP1c), thereby inhibiting fatty acid synthesis¹² (Figure 3). Interestingly, in C. elegans, PRY-1 promotes transcription of SREBP1 homolog SBP-1 to regulate fatty acid synthesis⁴^,²¹; however, the precise mechanism of this regulatory relationship is unknown. Another effector of PRY-1 appears to be the CREB-regulated transcriptional coactivator (CRTC) homolog.²² CRTC-1 is known to function downstream of AAK-2 and affects calcineurin-mediated lifespan and stress regulation in C. elegans.²³^,²⁴ While AMPK and calcineurin signaling in mammalian systems regulate CRTCs in an antagonistic manner, the involvement of Axin in this regulatory network remains to be determined.²⁵^–²⁸

Given that AMPK regulates many targets, it is expected that a subset may be co-regulated by AXIN. We recently reported that both pry-1 and aak-2 mutant transcriptomes significantly overlap with mutually up and downregulated genes. These common differentially expressed genes are associated with muscle structure development, muscle contraction, aging, and lipid metabolism. Moreover, we found that PRY-1-AAK-2 signaling functions in muscles leading to activation of AAK-2 in a cell-non-autonomous manner and phosphorylation and translocation of the FOXO transcription factor homolog DAF-16 into the intestinal cell nuclei⁴ (Figure 1). These results are supported by previous studies showing that activated DAF-16 is indispensable for muscle mitochondria homeostasis and lifespan extension. It is worth mentioning that FOXO3 is also phosphorylated by AMPK in the mammalian system; however, the involvement of AXIN in this process and the function of activated FOXO3 are unknown.²⁹

Unlike C. elegans, little is known about the role of AXIN and AMPK in regulating muscle health in another leading invertebrate model, namely the fruit fly D. melanogaster. Overexpression of D-axin in wing disc-associated myoblasts in larvae causes partial to complete loss of indirect flight muscles.³⁰ However, the precise role of D-axin and the involvement of AMPK and TORC1 in adult muscles is unknown. In terms of other processes, it has been reported that a hypomorphic allele of D-axin alters the expression of metabolic genes and is hypersensitive to metabolic stress induced by fasting. Such a phenotype depends on TORC1 activity and involves increased ROS production.³¹

Gaps in our knowledge

While much has been learned about Axin, AMPK, and their interactions, there are gaps in our understanding of the mechanisms regulating the complex formation, downstream effectors, and their role in maintaining muscle health. Some of the relevant questions are discussed below.

Is AXIN expression beneficial for muscle health?

The existing data supports that AXIN function in the muscle is beneficial. AXIN2 is required for myogenesis and linked to muscle aging, whereas AXIN1 mediated signaling is necessary for glucose uptake in the exercising muscles.¹¹^,¹⁵^,¹⁷ Both AXIN1 and AXIN2 are expressed in the skeletal muscle. Research in C. elegans hints that muscle-specific overexpression of pry-1 promotes mitochondrial network, muscle development, and muscle physiology.⁴ Whether such a role of Axin is conserved in higher eukaryotes is unknown.

Are AXIN1 and AXIN2 redundant in activating AMPK?

While AXIN1 and AXIN2 possess similar domains, they show differences in their regulation and expression pattern (subcellular localization and cell type-specific expression).¹⁴^,³² Additionally, AXIN2 is required for muscle development. Interestingly, exercise-induced glucose uptake requires AXIN1 in skeletal muscles. While it remains to be seen whether AXIN2 plays a redundant role in this process and regulates AMPK, Li et al.¹³ reported no change in AMPK activation following AXIN1 imKO in the skeletal muscle. Furthermore, Zong et al.¹² showed that AXIN2 could substitute AXIN1 in forming a complex between LKB1 and AMPK.

In C. elegans, PRY-1 and AXL-1 possess the characteristic domains for the AXIN family of proteins² and negatively regulate WNT signaling.³³^,³⁴ It has been shown that AXL-1 functions redundantly with PRY-1 to regulate the WNT effector protein BAR-1/β-catenin during the formation of the vulva and migration of Q neuroblast. However, both AXINs are functionally not equivalent and play roles independently to control specific processes. For example, PRY-1 is necessary for lipid metabolism, healthspan, lifespan, and seam cell development, whereas AXL-1 regulates excretory cell development.⁴^,²¹^,³³^–³⁶ Recent experiments from our lab also highlight functional differences between the two Axin proteins. While PRY-1 and AXL-1 are necessary for metformin-induced lifespan extension,⁷ only PRY-1 is required for glucose deprivation mediated longevity in C. elegans (Mallick et al., unpublished). These same treatments, i.e., metformin and glucose deprivation, are known to extend the lifespan in an AAK-2-dependent manner.³⁷^,³⁸ Overall, these studies demonstrate that AXIN homologs in every system have shared as well as unique functions. However, whether these proteins can redundantly activate AMPK remains to be investigated.

What factors limit AXIN-AMPK signaling?

Recent reports demonstrate that the lysosomal AXIN-AMPK signaling can be activated by glucose deprivation independently of AMP/ATP ratios. However, the medium-to-high elevation of AMP extends the activation of both cytosolic and lysosomal AMPK, which is also dependent on AXIN1.¹² By contrast, very high AMP levels phosphorylate AMPK in a manner that does not involve AXIN1 and probably occurs via a conformational change in AMPK. Whether AXIN-dependent activation of AMPK also requires a similar change in AMPK conformation is unclear. Furthermore, it is unknown how glucose levels facilitate the complex formation and differential activation of AMPK by LKB1.

Several other factors may also limit AXIN and AMPK mediated signaling. One of these is post-translational modification. AXIN activity is known to be regulated by phosphorylation.²^,³⁹^,⁴⁰ Another could be subcellular localization. While the AXIN-AMPK complex is localized to lysosomes and cytoplasm, the changes in their activities in response to external stimuli are poorly understood.¹⁰^,¹² Both factors are broadly expressed and in overlapping domains; however, whether their interactions are global or restricted to specific tissues remains to be determined. In this regard, it is worth mentioning that AMPK functions cell non-autonomously in C. elegans,²⁴ and we have reported that the protein is needed in both muscles and intestine to mediate beneficial effects of constitutive expression of AXIN in muscles.⁴

What are the effectors of AXIN-AMPK signaling?

Given that AMPK is involved in many different processes and regulates many downstream targets, one might expect that AXIN-AMPK interaction co-regulates a subset of the targets. In support of this, a recent paper suggests that AXIN-AMPK signaling phosphorylates targets that are different from ATP/AMP-dependent AMPK signaling.¹² As mentioned above, our analysis of C. elegans pry-1 and aak-2 transcriptomes has revealed many overlapping genes that are differentially expressed. However, more work is needed to identify and validate common targets of AXIN-AMPK signaling that are involved in maintaining muscle health in different systems. Identification of such target genes could lead to a better understanding of molecular mechanisms underlying the signaling network and the development of diagnostic markers and therapeutic interventions to promote muscle health.

New research directions

We envisage several exciting research avenues involving AXIN-AMPK signaling. While substantial knowledge has been gained in terms of processes that each one participates in and mechanisms underlying their function, little is known how the interactions between the two proteins are regulated, leading to changes in the expression of target genes that carry out various roles. Below are some of the potential research directions to address the questions in the previous section.

While it has been shown that the AXIN homologs in both C. elegans (PRY-1 and AXL-1) and mammalian systems (AXIN1 and AXIN2) can activate AMPK,⁴^,⁷^,⁹^,¹² the redundancies between the homologs and their tissue-specific interactions with AMPK are unknown. Moreover, the differences in lifespan and lipid metabolism phenotypes between the two AXIN mutants in C. elegans raise the question of functional equivalency regarding AMPK activation in physiological conditions. Future research along these lines should refine our understanding of AXIN-AMPK signaling and its conservation in eukaryotes.

Depending on the context, signaling pathways may utilize different mechanisms to regulate their responses. In this regard, research in the following areas should improve our understanding of the regulatory mechanism of AXIN-AMPK signaling. First, whether a conformational change in AMPK following AXIN binding occurs similar to the AMP-dependent mechanism. Second, the role of post-translational modification of AXIN in activating AMPK. Third, identifying a specific region of the multidomain AXIN protein required for AMPK interaction that, in turn, may uncover potential competitors to modulate the signaling. And, finally, the discovery of factors affecting subcellular localizations of both AXIN and AMPK and, in turn, their interactions.

Other modes of regulation of AXIN-AMPK signaling may include spatial and temporal changes in AXIN expression. AXIN is not only a negative regulator but also a downstream target of the WNT signaling.²¹^,⁴¹ Consistent with this, PRY-1/AXIN is required for MOM-2/WNT mediated lifespan regulation,⁴ and MOM-2 is expressed in the body wall muscles of C. elegans. It remains to be explored whether AXIN function in muscles is regulated in a WNT-dependent manner in eukaryotes.

Research from our group has shown that overexpression of PRY-1/AXIN in C. elegans extends the lifespan and improves muscle health in older adults. Whether forced expression of mammalian AXIN in muscles may also promote the healthspan of animals by activating AXIN-AMPK signaling requires investigation. In line with this, expression analysis of AXIN1 and AXIN2 in old adults and patients with a muscle disease should prove valuable.

As mentioned above, AXIN and AMPK are crucial for muscle development and physiology. Furthermore, exercise promotes the activation of AMPK in an AXIN-dependent manner. Given that exercise promotes muscle health and delays aging,⁴²^–⁴⁴ it is conceivable that AXIN and AMPK are involved in this process. More work is needed to understand the role of AXIN-AMPK signaling in exercise-mediated benefits.

Conclusion

AXIN family of scaffolding proteins control a wide array of cellular processes by recruiting multiple factors and forming protein complexes. One of the interactors of AXIN is the well-known energy sensor AMPK. AMPK functions as a nexus between energy conservation and aging, and perturbations of its function lead to various age-related pathologies. AXIN-AMPK signaling promotes muscle health and delays age-associated deterioration. Future studies on the pathway, its interacting proteins, and tissue-specific effectors hold promise to uncover key candidates that may be targeted in the future to delay age-associated muscle degeneration and improve muscle health during aging.

Data availability

No data are associated with this article.

Acknowledgements

Authors thank Gupta lab members for discussions on the topic and feedback on the manuscript. Figures were created using BioRender.

References

1. Wang Y, Wehling-Henricks M, Samengo G, et al.: Increases of M2a macrophages and fibrosis in aging muscle are influenced by bone marrow aging and negatively regulated by muscle-derived nitric oxide. Aging Cell. 2015; 14(4): 678–688. PubMed Abstract | Publisher Full Text | Free Full Text
2. Mallick A, Taylor SKB, Ranawade A, et al.: Axin Family of Scaffolding Proteins in Development: Lessons from C. elegans. J. Dev. Biol. 2019; 7(4): 1–23.
3. Hardie DG, Ross FA, Hawley SA: AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012; 13(4): 251–262. PubMed Abstract | Publisher Full Text | Free Full Text
4. Mallick A, Ranawade A, van den Berg W , et al.: Axin-Mediated Regulation of Lifespan and Muscle Health in C. elegans Requires AMPK-FOXO Signaling. iScience. 2020; 23(12): 101843. PubMed Abstract | Publisher Full Text | Free Full Text
5. Lee H, Jeong SC, Lambacher N, et al.: The Caenorhabditis elegans AMP-activated protein kinase AAK-2 is phosphorylated by LKB1 and is required for resistance to oxidative stress and for normal motility and foraging behavior. J. Biol. Chem. 2008; 283(22): 14988–14993. PubMed Abstract | Publisher Full Text | Free Full Text
6. Weir HJ, Yao P, Huynh FK, et al.: Dietary Restriction and AMPK Increase Lifespan via Mitochondrial Network and Peroxisome Remodeling. Cell Metab. 2017; 26(6): 884–896.e5. PubMed Abstract | Publisher Full Text | Free Full Text
7. Chen J, Ou Y, Li Y, et al.: Metformin extends C. Elegans lifespan through lysosomal pathway. elife. 2017; 6: 1–17. Publisher Full Text
8. Zhang CS, Li M, Ma T, et al.: Metformin Activates AMPK through the Lysosomal Pathway. Cell Metab. 2016; 24(4): 521–522. PubMed Abstract | Publisher Full Text
9. Zhang YL, Guo H, Zhang CS, et al.: AMP as a low-energy charge signal autonomously initiates assembly of axin-ampk-lkb1 complex for AMPK activation. Cell Metab. 2013; 18(4): 546–555. PubMed Abstract | Publisher Full Text
10. Zhang CS, Jiang B, Li M, et al.: The lysosomal v-ATPase-ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 2014; 20(3): 526–540. PubMed Abstract | Publisher Full Text
11. Yue Y, Zhang C, Zhang X, et al.: An AMPK/Axin1-Rac1 signaling pathway mediates contraction-regulated glucose uptake in skeletal muscle cells. Am. J. Physiol. Endocrinol. Metab. 2020; 318(3): E330–E342. PubMed Abstract | Publisher Full Text
12. Zong Y, Zhang CS, Li M, et al.: Hierarchical activation of compartmentalized pools of AMPK depends on severity of nutrient or energy stress. Cell Res. 2019; 29(6): 460–473. PubMed Abstract | Publisher Full Text | Free Full Text
13. Li J, Knudsen JR, Henriquez-Olguin C, et al.: AXIN1 knockout does not alter AMPK/mTORC1 regulation and glucose metabolism in mouse skeletal muscle. J. Physiol. 2021; 599(12): 3081–3100. PubMed Abstract | Publisher Full Text
14. Uhlén M, Fagerberg L, Hallström BM, et al.: Tissue-based map of the human proteome. Science (80-). 2015; 347(6220). PubMed Abstract | Publisher Full Text
15. Huraskin D, Eiber N, Reichel M, et al.: Wnt/β-catenin signaling via Axin2 is required for myogenesis and, together with YAP/Taz and tead1, active in IIa/IIx muscle fibers. Dev. 2016; 143(17): 3128–3142. PubMed Abstract | Publisher Full Text
16. Arthur ST, Cooley ID: The effect of physiological stimuli on sarcopenia; Impact of Notch and Wnt signaling on impaired aged skeletal muscle repair. Int. J. Biol. Sci. 2012; 8(5): 731–760. PubMed Abstract | Publisher Full Text | Free Full Text
17. Brack AS, Conboy MJ, Roy S, et al.: Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science (80-). 2007; 317(5839): 807–810. PubMed Abstract | Publisher Full Text
18. Thomson DM: The role of AMPK in the regulation of skeletal muscle size, hypertrophy, and regeneration. Int. J. Mol. Sci. 2018; 19(10). PubMed Abstract | Publisher Full Text | Free Full Text
19. Jensen TE, Wojtaszewski JFP, Richter EA: AMP-activated protein kinase in contraction regulation of skeletal muscle metabolism: Necessary and/or sufficient?. Acta Physiol. 2009; 196(1): 155–174. PubMed Abstract | Publisher Full Text
20. Kjøbsted R, Hingst JR, Fentz J, et al.: AMPK in skeletal muscle function and metabolism. FASEB J. 2018; 32(4): 1741–1777. PubMed Abstract | Publisher Full Text | Free Full Text
21. Ranawade A, Mallick A, Gupta BP: PRY-1/Axin signaling regulates lipid metabolism in Caenorhabditis elegans. PLoS One. 2018; 13(11): e0206540. PubMed Abstract | Publisher Full Text | Free Full Text
22. Mallick A, Taylor SKB, Mehta S, et al.: picd-1, a gene that encodes CABIN1 domain-containing protein, interacts with pry-1/Axin to regulate multiple processes in Caenorhabditis elegans. bioRxiv. 2021; 1–37.
23. Mair W, Morantte I, Rodrigues APC, et al.: Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature. 2011; 470(7334): 404–408. PubMed Abstract | Publisher Full Text | Free Full Text
24. Burkewitz K, Morantte I, Weir HJM, et al.: Neuronal CRTC-1 Governs Systemic Mitochondrial Metabolism and Lifespan via a Catecholamine Signal. Cell. 2015; 160(5): 842–855. PubMed Abstract | Publisher Full Text | Free Full Text
25. Screaton RA, Conkright MD, Katoh Y, et al.: The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell. 2004; 119(1): 61–74. PubMed Abstract | Publisher Full Text
26. Koo SH, Flechner L, Qi L, et al.: The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature. 2005; 437(7062): 1109–1114. PubMed Abstract | Publisher Full Text
27. Komiya T, Coxon A, Park Y, et al.: Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer. Oncogene. 2010; 29(11): 1672–1680. PubMed Abstract | Publisher Full Text | Free Full Text
28. Wang Y, Vera L, Fischer WH, et al.: The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis. Nature. 2009; 460(7254): 534–537. PubMed Abstract | Publisher Full Text | Free Full Text
29. Greer EL, Oskoui PR, Banko MR, et al.: The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 2007; 282(41): 30107–30119. Publisher Full Text
30. Benchabane H, Xin N, Tian A, et al.: Jerky/Earthbound facilitates cell-specific Wnt/Wingless signalling by modulating β-catenin-TCF activity. EMBO J. 2011; 30(8): 1444–1458. PubMed Abstract | Publisher Full Text | Free Full Text
31. Zhang T, Liao Y, Hsu FN, et al.: Hyperactivated Wnt Signaling Induces Synthetic Lethal Interaction with Rb Inactivation by Elevating TORC1 Activities. PLoS Genet. 2014; 10(5): e1004357. PubMed Abstract | Publisher Full Text | Free Full Text
32. Thul PJ, Akesson L, Wiking M, et al.: A subcellular map of the human proteome. Science (80-). 2017; 356(6340). PubMed Abstract | Publisher Full Text
33. Oosterveen T, Coudreuse DYM, Yang PT, et al.: Two functionally distinct Axin-like proteins regulate canonical Wnt signaling in C. elegans. Dev. Biol. 2007; 308(2): 438–448. PubMed Abstract | Publisher Full Text
34. Korswagen HC, DYM C, Betist MC, et al.: The Axin-like protein PRY-1 is a negative regulator of a canonical Wnt pathway in C. elegans. Genes Dev. 2002; 16(10): 1291–1302. PubMed Abstract | Publisher Full Text | Free Full Text
35. Mallick A, Ranawade A, Gupta BP: Role of PRY-1/Axin in heterochronic miRNA-mediated seam cell development. BMC Dev. Biol. 2019; 19(1): 1–12.
36. Mallick A, Gupta BP: Vitellogenin-2 acts downstream of PRY-1/Axin to regulate lipids and lifespan in C. elegans. microPublication Biol. 2020; 1: 19–21.
37. Onken B, Driscoll M: Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and SKN-1. PLoS One. 2010; 5(1): e8758. PubMed Abstract | Publisher Full Text | Free Full Text
38. Schulz TJ, Zarse K, Voigt A, et al.: Glucose Restriction Extends Caenorhabditis elegans Life Span by Inducing Mitochondrial Respiration and Increasing Oxidative Stress. Cell Metab. 2007; 6(4): 280–293. PubMed Abstract | Publisher Full Text
39. Tacchelly-Benites O, Wang Z, Yang E, et al.: Axin phosphorylation in both Wnt-off and Wnt-on states requires the tumor suppressor APC. PLoS Genet. 2018; 14(2): 1–24. Publisher Full Text
40. Wang Z, Tacchelly-Benites O, Yang E, et al.: Dual Roles for Membrane Association of Drosophila Axin in Wnt Signaling. PLoS Genet. 2016; 12(12): 1–26. Publisher Full Text
41. Jho E, Zhang T, Domon C, et al.: Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway. Mol. Cell. Biol. 2002; 22(4): 1172–1183. PubMed Abstract | Publisher Full Text | Free Full Text
42. Hartman JH, Smith LL, Gordon KL, et al.: Swimming Exercise and Transient Food Deprivation in Caenorhabditis elegans Promote Mitochondrial Maintenance and Protect Against Chemical-Induced Mitotoxicity. Sci. Rep. 2018; 8(1): 1–16.
43. Laranjeiro R, Harinath G, Burke D, et al.: Single swim sessions in C. elegans induce key features of mammalian exercise. BMC Biol. 2017; 15(1): 1–17. Publisher Full Text
44. Laranjeiro R, Harinath G, Hewitt JE, et al.: Swim exercise in Caenorhabditis elegans extends neuromuscular and gut healthspan, enhances learning ability, and protects against neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2019; 116(47): 23829–23839. PubMed Abstract | Publisher Full Text | Free Full Text

Comments on this article Comments (0)

Version 1

VERSION 1 PUBLISHED 08 Dec 2021

Author details Author details

¹ Department of Biology, McMaster University, Hamilton, Ontario, L8S4K1, Canada

Avijit Mallick
Roles: Conceptualization, Data Curation, Formal Analysis, Validation, Writing – Original Draft Preparation, Writing – Review & Editing

Bhagwati P. Gupta
Roles: Conceptualization, Funding Acquisition, Project Administration, Resources, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing

Competing interests

No competing interests were disclosed.

Grant information

This work was supported by Natural Sciences and Engineering Research Council (NSERC) Discovery grant to BPG and NSERC CGS-D graduate scholarship to AM.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Article Versions (1)

version 1

Published: 08 Dec 2021, 10:1259

https://doi.org/10.12688/f1000research.74220.1

Copyright

© 2021 Mallick A and Gupta BP. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download

Export To

metrics

	Views	Downloads
F1000Research	-	-
PubMed Central Data from PMC are received and updated monthly.	-	-

Citations

0

SEE MORE DETAILS

CITE

how to cite this article

Mallick A and Gupta BP. AXIN-AMPK signaling: Implications for healthy aging [version 1; peer review: 1 approved, 2 approved with reservations]. F1000Research 2021, 10:1259 (https://doi.org/10.12688/f1000research.74220.1)

NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.

track

receive updates on this article

Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?

Key to Reviewer Statuses VIEW HIDE

ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested

Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.

Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions

Version 1

VERSION 1

PUBLISHED 08 Dec 2021

Views

8

Reviewer Report 17 Jan 2022

Stefan Taubert, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada

Approved

https://doi.org/10.5256/f1000research.77950.r102286

This review/opinion article considers the roles of the two AXIN type proteins in AMPK signaling, focusing on muscle function and primarily on research done in C. elegans. The article nevertheless balances well what is known from different species, and highlights several ... Continue reading

This review/opinion article considers the roles of the two AXIN type proteins in AMPK signaling, focusing on muscle function and primarily on research done in C. elegans. The article nevertheless balances well what is known from different species, and highlights several areas for future investigation. The article is well written and the figures are useful.

There are no major issues, as the discussion is balanced and inclusive of knowledge gained from various systems. It would have perhaps been useful to compare what is known about the two different AXIN proteins in a table (interacting proteins, expression, location, etc) to highlight differences in an easily accessible resource.

Is the topic of the opinion article discussed accurately in the context of the current literature?

Yes
Are all factual statements correct and adequately supported by citations?

Yes
Are arguments sufficiently supported by evidence from the published literature?

Yes
Are the conclusions drawn balanced and justified on the basis of the presented arguments?

Yes

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: C. elegans, transcription, metabolism, stress response, longevity,

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

CITE

Report a concern

Respond or Comment

Views

14

Reviewer Report 06 Jan 2022

Anindya Ghosh Roy, Department of Cellular and Molecular Neuroscience, Nationa Brain Research Centre, Gurgaon, Haryana, India

Approved with Reservations

https://doi.org/10.5256/f1000research.77950.r108092

The ‘Opinion article’ by Mallick and Gupta focusses on the in vivo function of AXIN-AMPK axis in muscle homeostasis and organismal health/aging. AMPK has long been known to regulate energy production in the context of change of ATP level due ... Continue reading

The ‘Opinion article’ by Mallick and Gupta focusses on the in vivo function of AXIN-AMPK axis in muscle homeostasis and organismal health/aging. AMPK has long been known to regulate energy production in the context of change of ATP level due to stress, physical exercise etc. It has multiple functions and it is regulated by various means. The mode of its activation is different in response to differential levels of ATP depletion. Therefore figuring out the downstream effectors and biological effect in the context of differential levels of AMPK activation has been challenging.

There are various evidences in last few years that a scaffolding protein AXIN binds to AMPK and regulates the AMPK signaling positively. These evidences come from studying multiple model organisms including mice, flies and worms. The more recent finding from this group that AXIN and AMPK interaction plays an important role in delaying the muscle aging and organism level aging in C elegans model is very interesting (Mallick et al 2020). Moreover, the AMPK signaling helps the crosstalk between muscle and intestine to coordinate the aging process. Therefore, focusing on this topic to write this short review article is very timely and appropriate.

I have a few suggestions on the organization of this article.

First the authors should avoid referring to their article actively with phrases such as “study from our lab/group”. They may mention “recent study” instead.
I suggest that they first discuss the in vivo findings on AXIN-AMKP signaling in other organisms such as mice and flies in muscle health, ATP homeostasis etc. They can have a sub-heading for this. Then they can bring a separate sub-titled section, which describes the findings using worm model focusing their recent findings. Essentially, I am suggesting that they break the section titled ‘AXIN-AMPK signaling’ in two parts as suggested above. This will allow them to discuss the key interesting hypothesis coming out from their work.
One point to highlight in the future direction/question is how AXIN-AMPK signaling in muscles regulates the intestinal regulation of DAF-16. They can have a sub-title on this. Please suggest a few possibilities.
Another point is to propose some research questions on how AXIN intersects between Wnt and AMPK signaling. What are the interesting questions in this direction that can be solved using the worm model?

Is the topic of the opinion article discussed accurately in the context of the current literature?

Yes
Are all factual statements correct and adequately supported by citations?

Yes
Are arguments sufficiently supported by evidence from the published literature?

Yes
Are the conclusions drawn balanced and justified on the basis of the presented arguments?

Yes

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Genetics, C elegans, neural circuit development, neuronal regeneration, aging

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

CITE

Report a concern

Respond or Comment

Views

14

Reviewer Report 05 Jan 2022

Jonathan S. Oakhill, University of Melbourne, Melbourne, Vic, Australia

Approved with Reservations

https://doi.org/10.5256/f1000research.77950.r102289

The authors provide a largely balanced overview of current understanding regarding co-ordination between the energy sensor AMPK and well-defined scaffold protein AXIN1 to promote healthy aging, and succinctly outline knowledge gaps and future directions. A major question (for this protein ... Continue reading

The authors provide a largely balanced overview of current understanding regarding co-ordination between the energy sensor AMPK and well-defined scaffold protein AXIN1 to promote healthy aging, and succinctly outline knowledge gaps and future directions. A major question (for this protein biochemist at least) remains whether this occurs via direct interaction as the text and figures here suggest. Albeit an opinion piece, I think there is a degree of extrapolation and overstatement. For example, I could not find evidence in ref 7 to support the statement “...another C. elegans AXIN homolog AXL-1 forms a complex with AAK-2 following metformin treatment” on p3. Also AXIN2 redundancy has been demonstrated at the functional level, not structural, as stated on p6.

The AXIN1/AMPK complex was reported in 2013 but has not been independently verified as far as I’m aware. It is not a stretch to say the model has caused controversy in the field – mainly created by difficulty in replicating the primary co-IP and this should be given due accord. The authors published work using C. elegans notes that a physical interaction requires further examination.

I suggest the article would benefit from clearly distinguishing ‘function’ from ‘interaction’. I also recommend elaboration on the nature of the molecular interaction between AMPK and AXIN1, for which biochemical data are reported (eg Zhang et al, 2013 Fig 5). Authors could comment on requirement for AMPK b-subunit myristoylation for formation of the axin/AMPK complex in vitro. The non-myristoylatable mutant b2-G2A failed to localise to lysosomes following glucose starvation. Likewise requirement for the AXIN1 region between residues 507-731, which is indispensable for stabilisation of the complex in vitro but is outside of conserved AXIN1/2 domains.

Please expand on what is known of the major AXIN regulatory post translational modifications.

Is the topic of the opinion article discussed accurately in the context of the current literature?

Partly
Are all factual statements correct and adequately supported by citations?

Partly
Are arguments sufficiently supported by evidence from the published literature?

Partly
Are the conclusions drawn balanced and justified on the basis of the presented arguments?

Yes

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Metabolic signaling pathways; structural biology; cell biology

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

CITE

Report a concern

Respond or Comment

Comments on this article Comments (0)

Version 1

VERSION 1 PUBLISHED 08 Dec 2021

Open Peer Review

Reviewer Status

Reviewer Reports

	Invited Reviewers
	1	2	3
Version 1 08 Dec 21	read	read	read

Jonathan S. Oakhill, University of Melbourne, Melbourne, Australia
Anindya Ghosh Roy, Nationa Brain Research Centre, Gurgaon, India
Stefan Taubert, University of British Columbia, Vancouver, Canada

Comments on this article

All Comments(0)

Add a comment

Sign up for content alerts

Browse by related subjects

Back to all reports

Reviewer Report

8 Views

17 Jan 2022 | for Version 1

Stefan Taubert, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada

8 Views Cite this report Responses(0)

Approved

This review/opinion article considers the roles of the two AXIN type proteins in AMPK signaling, focusing on muscle function and primarily on research done in C. elegans. The article nevertheless balances well what is known from different species, and highlights several areas for future investigation. The article is well written and the figures are useful.

There are no major issues, as the discussion is balanced and inclusive of knowledge gained from various systems. It would have perhaps been useful to compare what is known about the two different AXIN proteins in a table (interacting proteins, expression, location, etc) to highlight differences in an easily accessible resource.

Is the topic of the opinion article discussed accurately in the context of the current literature?

Yes
Are all factual statements correct and adequately supported by citations?

Yes
Are arguments sufficiently supported by evidence from the published literature?

Yes
Are the conclusions drawn balanced and justified on the basis of the presented arguments?

Yes

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

C. elegans, transcription, metabolism, stress response, longevity,

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

14 Views

06 Jan 2022 | for Version 1

Anindya Ghosh Roy, Department of Cellular and Molecular Neuroscience, Nationa Brain Research Centre, Gurgaon, Haryana, India

14 Views Cite this report Responses(0)

Approved With Reservations

The ‘Opinion article’ by Mallick and Gupta focusses on the in vivo function of AXIN-AMPK axis in muscle homeostasis and organismal health/aging. AMPK has long been known to regulate energy production in the context of change of ATP level due to stress, physical exercise etc. It has multiple functions and it is regulated by various means. The mode of its activation is different in response to differential levels of ATP depletion. Therefore figuring out the downstream effectors and biological effect in the context of differential levels of AMPK activation has been challenging.

There are various evidences in last few years that a scaffolding protein AXIN binds to AMPK and regulates the AMPK signaling positively. These evidences come from studying multiple model organisms including mice, flies and worms. The more recent finding from this group that AXIN and AMPK interaction plays an important role in delaying the muscle aging and organism level aging in C elegans model is very interesting (Mallick et al 2020). Moreover, the AMPK signaling helps the crosstalk between muscle and intestine to coordinate the aging process. Therefore, focusing on this topic to write this short review article is very timely and appropriate.

I have a few suggestions on the organization of this article.

First the authors should avoid referring to their article actively with phrases such as “study from our lab/group”. They may mention “recent study” instead.
I suggest that they first discuss the in vivo findings on AXIN-AMKP signaling in other organisms such as mice and flies in muscle health, ATP homeostasis etc. They can have a sub-heading for this. Then they can bring a separate sub-titled section, which describes the findings using worm model focusing their recent findings. Essentially, I am suggesting that they break the section titled ‘AXIN-AMPK signaling’ in two parts as suggested above. This will allow them to discuss the key interesting hypothesis coming out from their work.
One point to highlight in the future direction/question is how AXIN-AMPK signaling in muscles regulates the intestinal regulation of DAF-16. They can have a sub-title on this. Please suggest a few possibilities.
Another point is to propose some research questions on how AXIN intersects between Wnt and AMPK signaling. What are the interesting questions in this direction that can be solved using the worm model?

Is the topic of the opinion article discussed accurately in the context of the current literature?

Yes
Are all factual statements correct and adequately supported by citations?

Yes
Are arguments sufficiently supported by evidence from the published literature?

Yes
Are the conclusions drawn balanced and justified on the basis of the presented arguments?

Yes

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Genetics, C elegans, neural circuit development, neuronal regeneration, aging

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

14 Views

05 Jan 2022 | for Version 1

Jonathan S. Oakhill, University of Melbourne, Melbourne, Vic, Australia

14 Views Cite this report Responses(0)

Approved With Reservations

The authors provide a largely balanced overview of current understanding regarding co-ordination between the energy sensor AMPK and well-defined scaffold protein AXIN1 to promote healthy aging, and succinctly outline knowledge gaps and future directions. A major question (for this protein biochemist at least) remains whether this occurs via direct interaction as the text and figures here suggest. Albeit an opinion piece, I think there is a degree of extrapolation and overstatement. For example, I could not find evidence in ref 7 to support the statement “...another C. elegans AXIN homolog AXL-1 forms a complex with AAK-2 following metformin treatment” on p3. Also AXIN2 redundancy has been demonstrated at the functional level, not structural, as stated on p6.

The AXIN1/AMPK complex was reported in 2013 but has not been independently verified as far as I’m aware. It is not a stretch to say the model has caused controversy in the field – mainly created by difficulty in replicating the primary co-IP and this should be given due accord. The authors published work using C. elegans notes that a physical interaction requires further examination.

I suggest the article would benefit from clearly distinguishing ‘function’ from ‘interaction’. I also recommend elaboration on the nature of the molecular interaction between AMPK and AXIN1, for which biochemical data are reported (eg Zhang et al, 2013 Fig 5). Authors could comment on requirement for AMPK b-subunit myristoylation for formation of the axin/AMPK complex in vitro. The non-myristoylatable mutant b2-G2A failed to localise to lysosomes following glucose starvation. Likewise requirement for the AXIN1 region between residues 507-731, which is indispensable for stabilisation of the complex in vitro but is outside of conserved AXIN1/2 domains.

Please expand on what is known of the major AXIN regulatory post translational modifications.

Is the topic of the opinion article discussed accurately in the context of the current literature?

Partly
Are all factual statements correct and adequately supported by citations?

Partly
Are arguments sufficiently supported by evidence from the published literature?

Partly
Are the conclusions drawn balanced and justified on the basis of the presented arguments?

Yes

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Metabolic signaling pathways; structural biology; cell biology

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Respond to this report

Responses (0)

[1] 1. Wang Y, Wehling-Henricks M, Samengo G, et al.: Increases of M2a macrophages and fibrosis in aging muscle are influenced by bone marrow aging and negatively regulated by muscle-derived nitric oxide. Aging Cell. 2015; 14(4): 678–688. PubMed Abstract | Publisher Full Text | Free Full Text

[2] 2. Mallick A, Taylor SKB, Ranawade A, et al.: Axin Family of Scaffolding Proteins in Development: Lessons from C. elegans. J. Dev. Biol. 2019; 7(4): 1–23.

[3] 3. Hardie DG, Ross FA, Hawley SA: AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012; 13(4): 251–262. PubMed Abstract | Publisher Full Text | Free Full Text

[4] 4. Mallick A, Ranawade A, van den Berg W , et al.: Axin-Mediated Regulation of Lifespan and Muscle Health in C. elegans Requires AMPK-FOXO Signaling. iScience. 2020; 23(12): 101843. PubMed Abstract | Publisher Full Text | Free Full Text

[5] 5. Lee H, Jeong SC, Lambacher N, et al.: The Caenorhabditis elegans AMP-activated protein kinase AAK-2 is phosphorylated by LKB1 and is required for resistance to oxidative stress and for normal motility and foraging behavior. J. Biol. Chem. 2008; 283(22): 14988–14993. PubMed Abstract | Publisher Full Text | Free Full Text

[6] 6. Weir HJ, Yao P, Huynh FK, et al.: Dietary Restriction and AMPK Increase Lifespan via Mitochondrial Network and Peroxisome Remodeling. Cell Metab. 2017; 26(6): 884–896.e5. PubMed Abstract | Publisher Full Text | Free Full Text

[7] 7. Chen J, Ou Y, Li Y, et al.: Metformin extends C. Elegans lifespan through lysosomal pathway. elife. 2017; 6: 1–17. Publisher Full Text

[8] 8. Zhang CS, Li M, Ma T, et al.: Metformin Activates AMPK through the Lysosomal Pathway. Cell Metab. 2016; 24(4): 521–522. PubMed Abstract | Publisher Full Text

[9] 9. Zhang YL, Guo H, Zhang CS, et al.: AMP as a low-energy charge signal autonomously initiates assembly of axin-ampk-lkb1 complex for AMPK activation. Cell Metab. 2013; 18(4): 546–555. PubMed Abstract | Publisher Full Text

[10] 10. Zhang CS, Jiang B, Li M, et al.: The lysosomal v-ATPase-ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 2014; 20(3): 526–540. PubMed Abstract | Publisher Full Text

[11] 11. Yue Y, Zhang C, Zhang X, et al.: An AMPK/Axin1-Rac1 signaling pathway mediates contraction-regulated glucose uptake in skeletal muscle cells. Am. J. Physiol. Endocrinol. Metab. 2020; 318(3): E330–E342. PubMed Abstract | Publisher Full Text

[12] 12. Zong Y, Zhang CS, Li M, et al.: Hierarchical activation of compartmentalized pools of AMPK depends on severity of nutrient or energy stress. Cell Res. 2019; 29(6): 460–473. PubMed Abstract | Publisher Full Text | Free Full Text

[13] 13. Li J, Knudsen JR, Henriquez-Olguin C, et al.: AXIN1 knockout does not alter AMPK/mTORC1 regulation and glucose metabolism in mouse skeletal muscle. J. Physiol. 2021; 599(12): 3081–3100. PubMed Abstract | Publisher Full Text

[14] 14. Uhlén M, Fagerberg L, Hallström BM, et al.: Tissue-based map of the human proteome. Science (80-). 2015; 347(6220). PubMed Abstract | Publisher Full Text

[15] 15. Huraskin D, Eiber N, Reichel M, et al.: Wnt/β-catenin signaling via Axin2 is required for myogenesis and, together with YAP/Taz and tead1, active in IIa/IIx muscle fibers. Dev. 2016; 143(17): 3128–3142. PubMed Abstract | Publisher Full Text

[16] 16. Arthur ST, Cooley ID: The effect of physiological stimuli on sarcopenia; Impact of Notch and Wnt signaling on impaired aged skeletal muscle repair. Int. J. Biol. Sci. 2012; 8(5): 731–760. PubMed Abstract | Publisher Full Text | Free Full Text

[17] 17. Brack AS, Conboy MJ, Roy S, et al.: Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science (80-). 2007; 317(5839): 807–810. PubMed Abstract | Publisher Full Text

[18] 18. Thomson DM: The role of AMPK in the regulation of skeletal muscle size, hypertrophy, and regeneration. Int. J. Mol. Sci. 2018; 19(10). PubMed Abstract | Publisher Full Text | Free Full Text

[19] 19. Jensen TE, Wojtaszewski JFP, Richter EA: AMP-activated protein kinase in contraction regulation of skeletal muscle metabolism: Necessary and/or sufficient?. Acta Physiol. 2009; 196(1): 155–174. PubMed Abstract | Publisher Full Text

[20] 20. Kjøbsted R, Hingst JR, Fentz J, et al.: AMPK in skeletal muscle function and metabolism. FASEB J. 2018; 32(4): 1741–1777. PubMed Abstract | Publisher Full Text | Free Full Text

[21] 21. Ranawade A, Mallick A, Gupta BP: PRY-1/Axin signaling regulates lipid metabolism in Caenorhabditis elegans. PLoS One. 2018; 13(11): e0206540. PubMed Abstract | Publisher Full Text | Free Full Text

[22] 22. Mallick A, Taylor SKB, Mehta S, et al.: picd-1, a gene that encodes CABIN1 domain-containing protein, interacts with pry-1/Axin to regulate multiple processes in Caenorhabditis elegans. bioRxiv. 2021; 1–37.

[23] 23. Mair W, Morantte I, Rodrigues APC, et al.: Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature. 2011; 470(7334): 404–408. PubMed Abstract | Publisher Full Text | Free Full Text

[24] 24. Burkewitz K, Morantte I, Weir HJM, et al.: Neuronal CRTC-1 Governs Systemic Mitochondrial Metabolism and Lifespan via a Catecholamine Signal. Cell. 2015; 160(5): 842–855. PubMed Abstract | Publisher Full Text | Free Full Text

[25] 25. Screaton RA, Conkright MD, Katoh Y, et al.: The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell. 2004; 119(1): 61–74. PubMed Abstract | Publisher Full Text

[26] 26. Koo SH, Flechner L, Qi L, et al.: The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature. 2005; 437(7062): 1109–1114. PubMed Abstract | Publisher Full Text

[27] 27. Komiya T, Coxon A, Park Y, et al.: Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer. Oncogene. 2010; 29(11): 1672–1680. PubMed Abstract | Publisher Full Text | Free Full Text

[28] 28. Wang Y, Vera L, Fischer WH, et al.: The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis. Nature. 2009; 460(7254): 534–537. PubMed Abstract | Publisher Full Text | Free Full Text

[29] 29. Greer EL, Oskoui PR, Banko MR, et al.: The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 2007; 282(41): 30107–30119. Publisher Full Text

[30] 30. Benchabane H, Xin N, Tian A, et al.: Jerky/Earthbound facilitates cell-specific Wnt/Wingless signalling by modulating β-catenin-TCF activity. EMBO J. 2011; 30(8): 1444–1458. PubMed Abstract | Publisher Full Text | Free Full Text

[31] 31. Zhang T, Liao Y, Hsu FN, et al.: Hyperactivated Wnt Signaling Induces Synthetic Lethal Interaction with Rb Inactivation by Elevating TORC1 Activities. PLoS Genet. 2014; 10(5): e1004357. PubMed Abstract | Publisher Full Text | Free Full Text

[32] 32. Thul PJ, Akesson L, Wiking M, et al.: A subcellular map of the human proteome. Science (80-). 2017; 356(6340). PubMed Abstract | Publisher Full Text

[33] 33. Oosterveen T, Coudreuse DYM, Yang PT, et al.: Two functionally distinct Axin-like proteins regulate canonical Wnt signaling in C. elegans. Dev. Biol. 2007; 308(2): 438–448. PubMed Abstract | Publisher Full Text

[34] 34. Korswagen HC, DYM C, Betist MC, et al.: The Axin-like protein PRY-1 is a negative regulator of a canonical Wnt pathway in C. elegans. Genes Dev. 2002; 16(10): 1291–1302. PubMed Abstract | Publisher Full Text | Free Full Text

[35] 35. Mallick A, Ranawade A, Gupta BP: Role of PRY-1/Axin in heterochronic miRNA-mediated seam cell development. BMC Dev. Biol. 2019; 19(1): 1–12.

[36] 36. Mallick A, Gupta BP: Vitellogenin-2 acts downstream of PRY-1/Axin to regulate lipids and lifespan in C. elegans. microPublication Biol. 2020; 1: 19–21.

[37] 37. Onken B, Driscoll M: Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and SKN-1. PLoS One. 2010; 5(1): e8758. PubMed Abstract | Publisher Full Text | Free Full Text

[38] 38. Schulz TJ, Zarse K, Voigt A, et al.: Glucose Restriction Extends Caenorhabditis elegans Life Span by Inducing Mitochondrial Respiration and Increasing Oxidative Stress. Cell Metab. 2007; 6(4): 280–293. PubMed Abstract | Publisher Full Text

[39] 39. Tacchelly-Benites O, Wang Z, Yang E, et al.: Axin phosphorylation in both Wnt-off and Wnt-on states requires the tumor suppressor APC. PLoS Genet. 2018; 14(2): 1–24. Publisher Full Text

[40] 40. Wang Z, Tacchelly-Benites O, Yang E, et al.: Dual Roles for Membrane Association of Drosophila Axin in Wnt Signaling. PLoS Genet. 2016; 12(12): 1–26. Publisher Full Text

[41] 41. Jho E, Zhang T, Domon C, et al.: Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway. Mol. Cell. Biol. 2002; 22(4): 1172–1183. PubMed Abstract | Publisher Full Text | Free Full Text

[42] 42. Hartman JH, Smith LL, Gordon KL, et al.: Swimming Exercise and Transient Food Deprivation in Caenorhabditis elegans Promote Mitochondrial Maintenance and Protect Against Chemical-Induced Mitotoxicity. Sci. Rep. 2018; 8(1): 1–16.

[43] 43. Laranjeiro R, Harinath G, Burke D, et al.: Single swim sessions in C. elegans induce key features of mammalian exercise. BMC Biol. 2017; 15(1): 1–17. Publisher Full Text

[44] 44. Laranjeiro R, Harinath G, Hewitt JE, et al.: Swim exercise in Caenorhabditis elegans extends neuromuscular and gut healthspan, enhances learning ability, and protects against neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2019; 116(47): 23829–23839. PubMed Abstract | Publisher Full Text | Free Full Text

AXIN-AMPK signaling: Implications for healthy aging

Abstract

Keywords

Introduction

AXIN-AMPK signaling

Figure 1. PRY-1/AXIN function in the muscle is necessary to maintain muscle health, mitochondrial biogenesis and longevity.

Figure 2. AXL-1/AXIN is required for metformin-mediated AAK-2/AMPK phosphorylation and longer lifespan in C. elegans.

Figure 3. AXIN forms a lysosomal complex, v-ATPase-Ragulator-AXIN/LKB1-AMPK, that is crucial for AMPK activation and the maintenance of energy homeostasis during stress-inducing conditions.

Downstream effectors of AXIN-AMPK signaling

Gaps in our knowledge

Is AXIN expression beneficial for muscle health?

Are AXIN1 and AXIN2 redundant in activating AMPK?

What factors limit AXIN-AMPK signaling?

What are the effectors of AXIN-AMPK signaling?

New research directions

Conclusion

Data availability

Acknowledgements

References

Comments on this article Comments (0)

Open Peer Review

Comments on this article Comments (0)

Open Peer Review

Reviewer Status

Reviewer Reports

Comments on this article

Browse by related subjects

Competing Interests Policy

Stay Updated